# GTF2A2

## Overview
GTF2A2 is a gene that encodes the general transcription factor IIA subunit 2, a critical component of the transcription machinery in eukaryotic cells. This protein is integral to the initiation of transcription by RNA polymerase II, where it participates in the formation of the transcription preinitiation complex. By interacting with the TATA-binding protein (TBP) and other transcription factors, the general transcription factor IIA subunit 2 stabilizes TBP's binding to DNA, thereby facilitating the assembly of the preinitiation complex and promoting mRNA synthesis (Di1999BriefCommunication:GenomicsoftheHumanGenesEncodingFourTAFIISubunitsofTFIID; Gao2023GTF2A1L). The gene is located on chromosome 15q21-q23 and is evolutionarily conserved, underscoring its importance in cellular processes (Di1999BriefCommunication:GenomicsoftheHumanGenesEncodingFourTAFIISubunitsofTFIID). GTF2A2 has been implicated in various diseases, including autoimmune disorders and cancer, highlighting its clinical significance in gene expression regulation and potential as a therapeutic target (Brünnert2023Ancistrocladinium; Cunningham2023Patients).

## Function
GTF2A2 encodes the general transcription factor IIA subunit 2, which plays a critical role in the initiation of transcription by RNA polymerase II. This protein is involved in the formation of the transcription preinitiation complex, a crucial step in the regulation of gene expression in eukaryotic cells. GTF2A2 interacts with the TATA-binding protein (TBP) and other transcription factors to stabilize TBP's binding to DNA, facilitating the assembly of the preinitiation complex (Gao2023GTF2A1L). This interaction is essential for promoter recognition and the initiation of mRNA synthesis, impacting cellular functions and organismal development (Di1999BriefCommunication:GenomicsoftheHumanGenesEncodingFourTAFIISubunitsofTFIID).

In healthy human cells, GTF2A2 is active in the nucleus, where it modulates transcriptional activity. Its function is vital for the proper regulation of gene expression, affecting processes such as chromatin decondensation and RNA synthesis (Di1999BriefCommunication:GenomicsoftheHumanGenesEncodingFourTAFIISubunitsofTFIID). The gene is present in a single copy in the human genome and is localized to chromosome 15q21-q23, highlighting its evolutionary conservation and importance in cellular processes (Di1999BriefCommunication:GenomicsoftheHumanGenesEncodingFourTAFIISubunitsofTFIID).

## Clinical Significance
The GTF2A2 gene has been implicated in several diseases and conditions due to its role in transcription regulation. Alterations in GTF2A2 expression have been associated with autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). In RA, autoantibodies against GTF2A2 are found in higher levels in both ACPA-positive and ACPA-negative subgroups compared to controls, although the specific role of GTF2A2 in RA remains unclear (Cunningham2023Patients). In SLE, point mutations in the expression quantitative trait loci (eQTL) of GTF2A2 are linked to type I interferon levels, suggesting a potential impact on immune regulation (Cunningham2023Patients).

GTF2A2 has also been studied in the context of cardiovascular diseases. It was included in a study investigating genes associated with myocardial infarction (MI) and coronary artery disease (CAD) due to its correlation with platelet function, although specific clinical implications of GTF2A2 mutations in these conditions were not detailed (Goodall2010Transcription).

In cancer research, GTF2A2 is frequently overexpressed in multiple myeloma cells, and its involvement in RNA transcription and splicing suggests it may play a role in tumor progression (Brünnert2023Ancistrocladinium).

## Interactions
GTF2A2, a component of the general transcription factor IIA (TFIIA) complex, plays a crucial role in the initiation of transcription by RNA polymerase II. It interacts with the TATA-binding protein (TBP) to stabilize the pre-initiation complex, facilitating promoter recognition and binding. This interaction is essential for the assembly of pre-initiation complexes and the regulation of transcription initiation rates (Gao2023GTF2A1L). GTF2A2 is also involved in transcriptional initiation processes, where it acts as a subunit of TFIIA, contributing to the transcriptional machinery's function (Di1999BriefCommunication:GenomicsoftheHumanGenesEncodingFourTAFIISubunitsofTFIID).

In the context of disease, GTF2A2 has been identified as a significant gene in obstructive sleep apnea (OSA), where it is highlighted as a hub gene with causal relationships to the condition. Although the study does not detail specific physical interactions, it underscores the gene's importance in the genetic framework of OSA (Gong2024Identification). Additionally, GTF2A2 has been associated with rheumatoid arthritis (RA), where it is noted as an autoantibody found in both ACPA-positive and ACPA-negative RA subgroups, suggesting its involvement in immunological processes (Cunningham2023Patients).


## References


1. (Di1999BriefCommunication:GenomicsoftheHumanGenesEncodingFourTAFIISubunitsofTFIID) Ref Di1999BriefCommunication:GenomicsoftheHumanGenesEncodingFourTAFIISubunitsofTFIID. This article has 2 citations.

[2. (Gong2024Identification) Nianjin Gong, Yu Tuo, and Peijun Liu. Identification and mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea. Frontiers in Neurology, August 2024. URL: http://dx.doi.org/10.3389/fneur.2024.1442835, doi:10.3389/fneur.2024.1442835. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2024.1442835)

[3. (Cunningham2023Patients) Kevin Y. Cunningham, Benjamin Hur, Vinod K. Gupta, Courtney A. Arment, Kerry A. Wright, Thomas G. Mason, Lynne S. Peterson, Delamo I. Bekele, Daniel E. Schaffer, Marissa L. Bailey, Kara E. Delger, Cynthia S. Crowson, Elena Myasoedova, Hu Zeng, Moses Rodriguez, Cornelia M. Weyand, John M. Davis, and Jaeyun Sung. Patients with acpa-positive and acpa-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity. Scientific Reports, April 2023. URL: http://dx.doi.org/10.1038/s41598-023-32428-4, doi:10.1038/s41598-023-32428-4. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-32428-4)

[4. (Brünnert2023Ancistrocladinium) Daniela Brünnert, Raina Seupel, Pankaj Goyal, Matthias Bach, Heike Schraud, Stefanie Kirner, Eva Köster, Doris Feineis, Ralf C. Bargou, Andreas Schlosser, Gerhard Bringmann, and Manik Chatterjee. Ancistrocladinium a induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate. Pharmaceuticals, 16(8):1181, August 2023. URL: http://dx.doi.org/10.3390/ph16081181, doi:10.3390/ph16081181. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ph16081181)

[5. (Goodall2010Transcription) Alison H. Goodall, Philippa Burns, Isabelle Salles, Iain C. Macaulay, Chris I. Jones, Diego Ardissino, Bernard de Bono, Sarah L. Bray, Hans Deckmyn, Frank Dudbridge, Desmond J. Fitzgerald, Stephen F. Garner, Arief Gusnanto, Kerstin Koch, Cordelia Langford, Marie N. O’Connor, Catherine M. Rice, Derek Stemple, Jonathan Stephens, Mieke D. Trip, Jaap-Jan Zwaginga, Nilesh J. Samani, Nicholas A. Watkins, Patricia B. Maguire, and Willem H. Ouwehand. Transcription profiling in human platelets reveals lrrfip1 as a novel protein regulating platelet function. Blood, 116(22):4646–4656, November 2010. URL: http://dx.doi.org/10.1182/blood-2010-04-280925, doi:10.1182/blood-2010-04-280925. This article has 82 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2010-04-280925)

6. (Gao2023GTF2A1L) GTF2A1L frameshift variant of a primary open angle glaucoma family from Chinese Han nationality. This article has 0 citations.